Cargando…
Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives
The tumor necrosis factor superfamily (TNFSF) and their receptors (TNFRSF) are important regulators of the immune system, mediating proliferation, survival, differentiation, and function of immune cells. As a result, their targeting for immunotherapy is attractive, although to date, under-exploited....
Autores principales: | Dadas, Osman, Ertay, Ayse, Cragg, Mark S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167284/ https://www.ncbi.nlm.nih.gov/pubmed/37180119 http://dx.doi.org/10.3389/fimmu.2023.1147467 |
Ejemplares similares
-
Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
por: Guo, Zong Sheng, et al.
Publicado: (2017) -
Immunotherapies Targeting Fish Mucosal Immunity – Current Knowledge and Future Perspectives
por: Koshio, Shunsuke
Publicado: (2016) -
Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy
por: Chester, Cariad, et al.
Publicado: (2015) -
TLR Agonists for Cancer Immunotherapy: Tipping the Balance between the Immune Stimulatory and Inhibitory Effects
por: Lu, Hailing
Publicado: (2014) -
Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future
por: Saura-Esteller, José, et al.
Publicado: (2022)